Vensa partners with Precision Driven Health

Vensa partners with Precision Driven Health to introduce clinical data science to primary healthcare

Innovative technology to automate the retrieval of lab results and analyse patterns for patient notifications on vensa.comis the focus of Vensa’s first PDH project

AUCKLAND, NZ, 24 September, 2018 – Vensa Health (www.vensa.com), a leading New Zealand digital health company, has joined forces with research initiative Precision Driven Health (PDH) to research and develop new technology which will focus on the clinical transformation journey for primary care providers. The technology aims to optimise clinical time and clinical decision making as well as increase capability and capacity for primary care clinicians.

The project is part of Vensa’s vision to make primary care more accessible, affordable and convenient via the vensa.com platform.

Precision Driven Health’s General Manager, Dr Kevin Ross, says: “Precision Driven Health is delighted to be working with Vensa towards a shared goal of creating a more accurate, personalised and efficient health system. We wholeheartedly support Vensa’s vision and this project really stood out as shared lab results is an area where data could be more meaningfully used to better deliver healthcare in New Zealand.”

Vensa Health CEO, Ahmad Jubbawey, says the partnership accelerates the development of clinical process optimisation efforts – the third wave in Vensa’s 10 year vision plan that the company recently released.

“Our first project with Precision Driven Health aims to provide valuable insight into analysing lab results with AI that will learn the clinical guidelines of the clinician. This will help to detect uncommon lab trends and even disseminate lab results on behalf of clinicians to patients. We already have clinical leadership committed to helping with research and development,” he says.

Clinical laboratory testing plays a crucial role in clinical care, from screening of patients to monitoring both chronic and acute conditions. Tens of thousands of lab tests are ordered in primary care and processed daily across New Zealand. This equates to millions of lab test results to be interpreted by clinicians and explained to patients on a yearly basis, resulting from around 18 million annual GP visits.

Jubbawey says, “Working closely with primary care organisations we saw an opportunity to retrieve lab results data from patient management systems (PMS) and other sources to help clinicians and patients alike.”

Dr Jason Hwang, a global expert in disruptive healthcare innovation who co-authored The Innovator's Prescription: A Disruptive Solution for Health Care with Clayton Christensen, and a Principal Investigator of the study says, “The project aims to accurately automate and disseminate lab results to improve clinical decision making and save a clinician’s time. We’re also interested in how insights from collective clinical best practice could be used to identify lab results patterns from longitudinal trends that could lead to new recommendations for interpreting individual lab results.”

“There is great value to be gained from using technology to automate and analyse lab results and deliver these accurately, inexpensively and in a timely matter to patients via patient alerts. Globally, an increasing number of patients are becoming proponents of new digital health tools that improve and personalise medical care, and disruptive innovation like this will help meet those needs.”

Jubbawey, says the project has the potential to advance the role of automation and AI in clinical decision making and dramatically improve a clinician’s workload at the same time.

“I have had many GPs come to me and say that they are working until midnight every day to process lab results. Providing GPs with a tool that extends their clinical guidelines will free up a lot of valuable time. It’s really exciting for us to help serve primary care providers as part of the vensa.com suite.”

Precision Driven Health was set up to support a thriving health IT capability in New Zealand, applying data science to develop tools that improve health.

Dr Ross says, “Vensa are an ideal partner for us as they’re a successful health IT business with plans to export globally. Vensa have already demonstrated a clear pathway from research to development and implementation, firstly with TXT2Remind which is used by close to 70% of GP practices in the country, and more recently with their platform vensa.com which targets a new delivery model for healthcare which this research supports.”

The three-year research project commences this month. For further information, please visit precisiondrivenhealth.com for the project summary.

ENDS

© Scoop Media